U.S. Clinical Trial Management Systems Markets

Published by: Frost & Sullivan

Published: Apr. 18, 2008 - 59 Pages

Table of Contents

1. U.S. Clinical Trial Management Systems Markets

1. Introduction and Scope

1. Disclaimer

2. Certification

3.. Table of Contents

4. Research Methodology and Scope

2. Market Overview

1. Market Overview

2. Electronic Data Flow in Clinical Trials

3. Market Drivers and Trends

1. Market Drivers

2.. CRO Market Share by Revenues

3.. Demand Side Drivers

4.. Demand Side Trends

5.. Market Trends Workforce Analysis CRO

6. Percent of Total Employees CRO Market

7. Market Drivers and Trends Demand Side Biopharma

8. Data Management Allocations

4. Challenges and Data Management Needs

1. Industry Challenges

2. Data Management Needs of Mid-Size CROs

3. Increasing Need for Complete CTMS

5. Revenue Forecasts and Market Analysis

1. Revenue Forecasts

2. Revenue Forecasts Analysis

3. Top Five Evaluation Factors for Choosing CTMS Vendor

4. Key Criteria for Evaluating a CTMS Vendor

6. Market Share and Pricing Models

1. Market Share Trends

2. Company Market Share

3. Company Market Share Analysis

4. Pricing Models

5. Pricing Models Analysis

6. Purchasing Cycle of CTMS Solutions

7. Vendor Profiles

1. Oracle Clinical

2. Phase Forward

3. eResearch Technology

4. Perceptive Informatics

5. Medidata

6. Nextrials

7. ClinPhone

8. Conclusion

1. Conclusion

2. Clinical Trial Management Systems

9. About Frost and Sullivan

1. About Frost and Sullivan

Abstract

This Frost & Sullivan research service titled U.S. Clinical Trial Management Systems Markets provides trends of clinical trials management systems (CTMS) market, offering detailed market forecasts, vendor analysis, and market shares. Market segmentation has been based on the type of product. The study includes electronic data capture (EDC) packages that are bundled with additional modules to serve as CTMS.

Clinical Trial Management Systems’ Ability to Provide Visibility of Real-time Data to End users Holds it in Good Stead

As clinical trials go global, sponsor companies and contract research organization (CROs) are increasingly looking for tools that will help them simultaneously view, manage, and discuss these trials across multiple sites. They are hoping to obtain an edge in the highly competitive healthcare industry by using technology to shorten project times, improve data quality, and thus, differentiate services. These tools will also enable the CRO to collaborate with clients and contribute key information that enhances data quality. Clinical trial management systems (CTMS) have emerged as the solution that is best suited to provide this advantage to CROs.

CTMS employs intelligent applications and access to clean data to help users improve overall efficiency and shorten trial timelines, which, in turn, lowers overall cost through better utilization of resources. The systems use automated data checks to ensure this, thereby reducing the need for expensive back-end queries and reconciliation. "CTMS also has the potential to enable decision making and improve patient safety protection," says the analyst of this research service. "The success of implementing electronic data capture (EDC) solutions is a strong driver for the implementation of CTMS solutions."

CTMS Vendors Need to Prepare to Interact Directly with Clients

CROs are under increasing pressure to explain the rapid rise in the number of post-marketing adverse events. This is driving them to invest in tools that capture and manage trial data more effectively. While this trend is likely to gladden vendors of the highly dynamic CMTS market, participants will also have to prepare for the eventual maturing of the market. Once this happens, system vendors will have to increasingly deal directly with CROs, which will be the primary decision maker while choosing the vendor. CROs will be conscientious while selecting a CMTS vendor to conduct business with, since sponsors will prefer CROs that function as a one-stop shop and offer integrated solutions for running and managing trials.

"Meanwhile, the cost and resource implications for smaller CROs and BioPharma companies in CTMS implementation are significant," notes the analyst. "It is important to account for ‘hidden costs’ while calculating the total cost of deployment and operation of CTMS solutions."

Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.